Acknowledgement

This activity is provided by Talem Health and RME Collaborative.

In collaboration with the Southeast AIDS Education & Training Center.

This activity is supported by an independent educational grant from Gilead Sciences, Inc.

Credit Available

• Physicians — maximum of 1.5 AMA PRA Category 1 Credits™
• Nurses — 1.5 Contact Hours (1.0 contact hour of pharmacotherapy credit)
• Pharmacists — 1.5 Contact Hours (0.15 CEU)

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

This activity is designed specifically for primary care clinicians including physicians, nurse practitioners, physician assistants, nurses, pharmacists, and other members of the healthcare team who care for patients from rural and underserved communities. 

Program Overview

The Southeastern United States continues to bear a disproportionate burden of HIV, with rural and underserved communities facing additional challenges, including limited healthcare resources, geographic barriers to care, and shortages of infectious disease specialists. Pre-exposure prophylaxis (PrEP) is highly effective for preventing HIV, underscoring the need for clinicians in these settings to understand its use and engage patients in conversations about sexual health. In Part 1 of this two-part series, HIV Prevention: Closing Gaps in PrEP Access in Rural and Underserved Communities of the Southeast US, expert faculty will review current and emerging PrEP options, evolving clinical evidence, and key challenges in HIV prevention and care. Best practices for discussing sexual health, identifying patients who may benefit from PrEP, and expanding access to PrEP in rural and underserved communities will also be explored. 

This activity is a recording from a two-part webinar series that took place in June 2026. 

Learning Objectives

Upon completion of this activity, participants should be better able to: 

• Apply best practices for routine sexual history-taking to identify patients who may be at risk for HIV acquisition in rural and underserved clinical settings  
• Use patient-centered communication strategies to assess HIV risk and counsel appropriate patients about PrEP as an effective HIV prevention option
• Assess the clinical evidence on the efficacy, safety, and dosing profiles of available and emerging PrEP formulations
• Incorporate current guideline recommendations for initiating, monitoring, and discontinuing PrEP in patients at risk for HIV acquisition

Faculty

Onyema E. Ogbuagu, MBBCh, FACP, FIDSA   
Professor of Medicine and of Pharmacology 
Director, Antivirals and Vaccines Research Program   
Yale School of Medicine   
Attending Physician, Infectious Diseases   
Yale New Haven Health, Yale Medicine    
New Haven, CT

Cody A. Chastain, MD, MEHP, FACP, FIDSA 
Associate Professor of Medicine 
Vanderbilt Health  
Nashville, TN
 

Joint Accreditation Statement

In support of improving patient care, Talem Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement

Physician Continuing Medical Education
Talem Health designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours. Designated for 1.0 contact hour of pharmacotherapy credit for Advanced Practice Registered Nurses.

Continuing Pharmacy Education
Talem Health designates this continuing education activity for 1.5 contact hours (0.15 CEU) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number – JA4008332-0000-26-054-H01-P)
Type of Activity: Application

Disclosure of Conflicts of Interest

Talem Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All identified conflicts of interest are thoroughly vetted and mitigated according to Talem Health policy. Talem Health is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Faculty

Onyema E. Ogbuagu, MBBCh, FACP, FIDSA, has disclosed the following relevant financial relationships: consultant/advisory board member for Gilead Sciences, Inc. and ViiV Healthcare.

Cody A. Chastain, MD, MEHP, FACP, FIDSA, has no relevant financial relationships to disclose.

Planners, Managers, and Reviewer

None of the Talem Health staff (planners, managers, or reviewer) for this educational activity have relevant financial relationship(s) to disclose with ineligible companies.

Instructions for Participation and Credit

This activity is offered at no cost to participants. To receive CME credit, participants must:

1. Read the CME/CE information, including learning objectives and disclosure statements.
2. Complete the pre-test.
3. View the online activity.
4. Complete the post-test and evaluation form.

A post-test score of 67% or higher is required to obtain credit. Your certificate will be made available for immediate download.

Course Viewing Requirements

Supported Browsers:
Desktop/laptop: Newest and last prior version of Google Chrome, Firefox, Safari, and Microsoft Edge  
Mobile devices: Newest and last prior version of Safari and Google Chrome

Supported Phones & Tablets:
All devices

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

©RME Collaborative, a division of Talem Health, LLC. All Rights Reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Talem Health, LLC is prohibited.

Media

Internet activity

Fee Information

There is no fee for this educational activity.

Contact Information

For questions about this activity, please contact RME Collaborative (a division of Talem Health) at 800-913-9370 or cme@cmeruralhealth.com. 

Additional Activity in This Series

• Bringing PrEP to Patients: Case-Based Strategies to Optimize Care in Rural and Underserved Communities